Trials / Conditions / Total Neoadjuvant Treatment

Total Neoadjuvant Treatment

8 registered clinical trials studyying Total Neoadjuvant Treatment — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC NCT07198165	Ruijin Hospital	Phase 2
Recruiting	Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell NCT06764355	National Taiwan University Hospital	Phase 2
Recruiting	Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830	National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos	Phase 2 / Phase 3
Active Not Recruiting	Study of Daily Step Count and Treatment Response in Rectal Cancer (STEP-R) NCT06668402	Gazi University	—
Not Yet Recruiting	Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal Canc NCT05998122	The First Hospital of Jilin University	Phase 2
Active Not Recruiting	Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer NCT04906044	The First Hospital of Jilin University	Phase 1
Unknown	Short-course Radiotherapy With Induction and Consolidation Chemotherapy in Patients With Locally Advanced Rect NCT04674696	Instituto Nacional de Cancer, Brazil	Phase 2
Unknown	Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors NCT03177382	West China Hospital	Phase 3